With Boston as a leading biotech hub for clinical trials and through partnering with MassBio we are going to expand our reach in the area to have senior representatives from all biotech’s to explore oncology trials whilst remaining operationally focused.
With a dynamic 2018 programme written for the industry, by the industry, this year promises to be truly engaging and informative.